NCT02842645

Brief Summary

"Children exposed to alcohol or drugs during pregnancy: Growth, health and development" Background Children exposed to drugs during pregnancy are at risk of developmental disorders. The scope and size of this problem is poorly known in Norway. Alcohol has a known teratogenic effect on the fetus. How other drugs affect the fetus, is associated with more uncertainty. Withdrawal in the neonatal period has been perceived as the main problem. There is less knowledge about long-term outcome of exposure to drugs during pregnancy. Aim The aim of the study is to investigate the physical and mental health of children exposed to drugs during pregnancy. Identify the children's need for measures in the home and school, and how many of the children who are taken care of in fostercare. A sample of the children will be offered radiological examination of the brain (f-MRI). The purpose is to study the relationship between exposure to drugs, child development, environment and organic brain dysfunction. Design The project is a quantitative study. The relationship between exposure to drugs and development will be measured by questionnaires, clinical examination, neuropsychological tests and radiological examination (f-MRI). Children aged 2-15years who were referred, examined or treated for drug related problems at the Department of Pediatrics, Haukeland University Hospital will be invited to participate in the study. Information retrieval and examination of the children are expected to be completed during 2011. Data analysis and further processing of data are expected to be completed during 2013.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2011

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 1, 2011

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
3.2 years until next milestone

First Posted

Study publicly available on registry

July 25, 2016

Completed
Last Updated

August 17, 2016

Status Verified

August 1, 2016

Enrollment Period

1.8 years

First QC Date

April 1, 2011

Last Update Submit

August 16, 2016

Conditions

Keywords

Foetal Exposure During PregnancyHealthGrowth

Outcome Measures

Primary Outcomes (1)

  • Mental Health Disorder

    Questionaire regarding mental health: Strength and Difficulties Questionnaires

    2012

Other Outcomes (1)

  • Social status

    2012

Study Arms (2)

Control

Children born at term and not exposed to drugs during pregnancy

Case

Case = Children exposed to drugs during pregnancy

Eligibility Criteria

Age2 Years - 15 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children exposed to drugs during pregnancy are followed up at school age regarding mental disorders and status of their care situation. Approximately 130 children are invited to the study.

You may qualify if:

  • Foetal exposure of drugs during pregnancy.

You may not qualify if:

  • Non exposed children

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Haukeland universitet sykehus

Bergen, 5021, Norway

Location

Haukelans universitetssykehus

Bergen, 5021, Norway

Location

MeSH Terms

Conditions

Failure to ThriveMental Disorders

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Irene B Elgen, Professor

    Department of Child and Adolscent Psychiatry, Haukeland University Hospital, N-5018 Bergen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2011

First Posted

July 25, 2016

Study Start

February 1, 2011

Primary Completion

December 1, 2012

Study Completion

May 1, 2013

Last Updated

August 17, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

Locations